Cleocin HCl is the U.S. brand name for oral clindamycin hydrochloride capsules, a systemic prescription antibiotic. The labeled capsule strengths include 75 mg, 150 mg and 300 mg. This brand should not be confused with Cleocin T skin products or Cleocin vaginal formulations. For the route-level context, see oral clindamycin and the oral capsule product guide.
A pharmacy listing should be checked for the full name “Cleocin HCl,” oral capsule route and prescribed strength. A label, product catalogue or historical package image may document the brand but does not confirm current shelf stock or a patient’s insurance coverage. The pharmacist determines the actual dispensed brand or appropriate generic according to the prescription.
This page is a brand entity guide focused on the hydrochloride capsule family, labeled identity and lawful U.S. access. For a direct brand-versus-generic discussion, use the Cleocin vs generic comparison; pediatric liquid is a different branded product.
Cleocin HCl contains clindamycin hydrochloride as an oral capsule, with strength stated in terms of clindamycin in the U.S. label. It is a lincosamide antibiotic used for certain susceptible bacterial infections when a clinician determines the indication and risks justify its use.
The capsule is swallowed as prescribed. It must not be repurposed as an acne topical, a vaginal preparation or a pediatric oral liquid. The exact diagnosis and treatment course belong to clinical care rather than brand shopping.
| Label element | Cleocin HCl capsule family | Common confusion |
|---|---|---|
| Active ingredient | Clindamycin hydrochloride | Clindamycin phosphate topical product |
| Route | Oral capsule | Skin gel or vaginal cream |
| Strengths | 75 mg, 150 mg, 300 mg | 75 mg/5 mL liquid concentration |
| Prescription | Valid U.S. prescription | No-prescription advertisement |
| Alternative | Appropriate generic HCl capsule when allowed | Different route or formulation |
| Important warning | C. difficile-associated diarrhea / colitis | Assuming topical safety profile |
DailyMed labeling for Cleocin HCl includes 75 mg, 150 mg and 300 mg oral capsules. Those numbers identify marketed dosage strength families, not a recommendation about how much an individual should take. A prescription may specify a particular strength, number of units and treatment directions.
To verify a specific product family, see 75 mg, 150 mg and 300 mg capsule pages. Do not switch strength to minimize capsule count without prescriber or pharmacist authorization.
The Cleocin HCl label instructs patients to take the capsules with a full glass of water (approximately 6–8 ounces) and to remain upright for at least 30 minutes before lying down. This is a product-specific precaution intended to reduce esophageal irritation; a simple capsule-strength comparison will not reveal it. Follow the complete instructions provided with the prescribed medicine.
People who have difficulty swallowing a capsule, symptoms of esophageal irritation, or uncertainty about their instructions should consult the pharmacist or prescriber. Do not open capsules, switch to oral liquid, or alter the schedule on your own. Oral clindamycin solution is a distinct prescription dosage form with separate preparation and measurement requirements.
Generic clindamycin hydrochloride capsules may be dispensed when they are appropriately equivalent to the prescribed brand and substitution is permitted. The pharmacist checks the exact strength and dosage form rather than treating every generic clindamycin product as equivalent.
The generic clindamycin overview explains how oral, topical and vaginal generic entries differ. A generic topical gel or oral solution is not a substitute for an oral Cleocin HCl capsule.
In the United States, Cleocin HCl is prescription-only. A pharmacy should validate the order, confirm the requested strength and quantity, and review any permissible generic substitutions. A legitimate online seller also needs a valid prescription and verifiable dispensing credentials.
Our online pharmacy checks explain how to identify licensed sellers and pharmacist contact. Neither this page nor a DailyMed label promises current brand availability at a particular store.
Oral clindamycin has a serious boxed warning for Clostridioides difficile-associated diarrhea, which can range from mild diarrhea to life-threatening colitis. Treatment should be reserved for clinically appropriate situations because the risk can be significant even after antibiotic exposure has ended.
Clinicians weigh this risk against the infection being treated and other antibiotic options. The C. difficile risk page provides additional context, including reasons to seek urgent assessment for severe or persistent diarrhea.
Cleocin HCl is formally contraindicated for a person with a history of hypersensitivity to clindamycin- or lincomycin-containing products. Tell the prescriber about prior hives, swelling, breathing difficulty, severe rash or other suspected reactions rather than assuming a different brand or manufacturer avoids the issue. A history of gastrointestinal disease, especially colitis, also warrants careful prescribing review because of the serious C. difficile warning.
A product-information site cannot determine whether a particular infection is susceptible to clindamycin or whether another antibiotic would be safer. Those decisions require an assessment and, when appropriate, diagnostic testing.
Look for “clindamycin hydrochloride capsule,” the prescribed mg strength, oral route and a brand indicator if the clinician ordered Cleocin HCl. Pharmacy inventory systems sometimes use shortened descriptions, so ask the pharmacist to confirm an ambiguous label before accepting a substitute.
Check the dispensed patient label against the prescription and supplied medicine. Bottle photographs and NDC examples can help identify product history, but they do not establish the specific item currently in a pharmacy’s stock.
Manufacturer labeling may describe stock bottles containing many capsules, while a patient normally receives the quantity authorized by the prescription. A 100-capsule manufacturer bottle does not mean a patient needs 100 capsules, and a product-strength number is not a full dosing instruction.
Ask the pharmacist to explain the actual dispensed quantity, directions, storage and what to do if the label is unclear. Avoid making treatment changes based on manufacturer-pack descriptions found online.
A branded capsule may face different formulary rules than an appropriate generic. Coverage may depend on strength, quantity, plan preference, pharmacy network and deductible. A price from one transaction cannot be assumed for another insurance plan.
For ongoing evergreen cost considerations see clindamycin capsule pricing. Contact the pharmacy for a patient-specific brand and generic quote before making decisions.
Confirm the oral route, clindamycin hydrochloride ingredient, prescribed 75/150/300 mg strength, authorized quantity, pharmacy label and the boxed C. difficile warning. Verify that any brand-to-generic substitution is lawful and correctly documented.
Cleocin HCl is one specific branded capsule product; it should not be treated as a shorthand for every clindamycin product. The right medicine is the clinician-prescribed product verified by a licensed pharmacist.
A prescription brand of clindamycin hydrochloride oral capsules for appropriate bacterial infections.
U.S. labeling includes 75 mg, 150 mg and 300 mg capsules.
No. Cleocin HCl is an oral capsule; Cleocin T is a topical skin product family.
No. Cleocin Pediatric is associated with oral liquid formulation; the products differ in dosage form and pharmacy preparation.
An appropriate generic oral capsule may be dispensed when permitted by the prescription and applicable rules.
No. U.S. dispensing requires a valid prescription.
No. Check current availability with the dispensing pharmacy.
Oral clindamycin can cause serious C. difficile-associated diarrhea and colitis; a clinician weighs that risk before prescribing.
Follow the prescription label. The branded labeling calls for a full glass of water and remaining upright for at least 30 minutes before lying down to reduce esophageal irritation.